190 related articles for article (PubMed ID: 16361046)
1. Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions.
Kaplan GG; Bates D; McDonald D; Panaccione R; Romagnuolo J
Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1207-14. PubMed ID: 16361046
[TBL] [Abstract][Full Text] [Related]
2. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.
Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R
Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361
[TBL] [Abstract][Full Text] [Related]
3. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
Enns R; Andrews CN; Fishman M; Hahn M; Atkinson K; Kwan P; Levy A
Can J Gastroenterol; 2004 Sep; 18(9):567-71. PubMed ID: 15457296
[TBL] [Abstract][Full Text] [Related]
4. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
Jensen DM; Pace SC; Soffer E; Comer GM;
Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
[TBL] [Abstract][Full Text] [Related]
5. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage?
Guda NM; Noonan M; Kreiner MJ; Partington S; Vakil N
Am J Gastroenterol; 2004 Jul; 99(7):1233-7. PubMed ID: 15233659
[TBL] [Abstract][Full Text] [Related]
6. The clinical importance of proton pump inhibitor pharmacokinetics.
Yacyshyn BR; Thomson AB
Digestion; 2002; 66(2):67-78. PubMed ID: 12428065
[TBL] [Abstract][Full Text] [Related]
7. Less acid + less bleeding = better outcomes and more money!
Enns R
Can J Gastroenterol; 2004 Dec; 18(12):747-8; discussion 748. PubMed ID: 15605140
[No Abstract] [Full Text] [Related]
8. Intravenous pantoprazole utilization in a level 1 trauma center.
Edelman DA; Patel KR; Tyburski JG; Zimmerman LG
Surg Endosc; 2008 Apr; 22(4):967-73. PubMed ID: 17710489
[TBL] [Abstract][Full Text] [Related]
9. Intravenous proton pump inhibitor therapy: a rationale for use.
Armstrong D
Rev Gastroenterol Disord; 2005; 5 Suppl 2():S18-30. PubMed ID: 16369224
[TBL] [Abstract][Full Text] [Related]
10. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers.
Hsu PI; Lo GH; Lo CC; Lin CK; Chan HH; Wu CJ; Shie CB; Tsai PM; Wu DC; Wang WM; Lai KH
World J Gastroenterol; 2004 Dec; 10(24):3666-9. PubMed ID: 15534928
[TBL] [Abstract][Full Text] [Related]
11. [Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence].
Bustamante Baléna M; Ponce García J
Rev Clin Esp; 2004 Mar; 204(3):161-8. PubMed ID: 15025985
[No Abstract] [Full Text] [Related]
12. The novel use of an intravenous proton pump inhibitor in a patient with short bowel syndrome.
Tang SJ; Nieto JM; Jensen DM; Ohning GV; Pisegna JR
J Clin Gastroenterol; 2002 Jan; 34(1):62-3. PubMed ID: 11743248
[TBL] [Abstract][Full Text] [Related]
13. [Visual documentation of the stability of intravenous solutions of omeprazole (Losec) and pantoprazole (Pantoloc)].
Leitner A; Zöllner P
Wien Med Wochenschr; 2002; 152(21-22):568-73. PubMed ID: 12506681
[TBL] [Abstract][Full Text] [Related]
14. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
16. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.
Regula J; Butruk E; Dekkers CP; de Boer SY; Raps D; Simon L; Terjung A; Thomas KB; Lühmann R; Fischer R
Am J Gastroenterol; 2006 Aug; 101(8):1747-55. PubMed ID: 16817839
[TBL] [Abstract][Full Text] [Related]
17. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
Craig DG; Thimappa R; Anand V; Sebastian S
QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors: a study of GPs' prescribing.
Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
[TBL] [Abstract][Full Text] [Related]
19. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
[TBL] [Abstract][Full Text] [Related]
20. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
Martin RA
Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]